Abstract
Different approaches have been made on reducing the risk of acute or subacute reocclusion of stented coronary vessels. To date, no definite solution of these complications has been established. Therefore, we compared the efficaciousness of different dosages of ticlopidine (Tiklyd, Sanofi Winthrop, FRG) and acetylsalicylic acid (ASA, Aspirin, Bayer, Germany), focusing on platelet inhibition by aggregometry and in an in vitro circulating model containing coronary stents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Brockmann, M.A. et al. (2001). Between-Drug Comparison of the Effect of Ticlopidine and Acetylsalicylic Acid on Platelets in an In Vitro Circulation Model. In: Scharrer, I., Schramm, W. (eds) 30th Hemophilia Symposium Hamburg 1999. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18240-2_59
Download citation
DOI: https://doi.org/10.1007/978-3-642-18240-2_59
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67677-5
Online ISBN: 978-3-642-18240-2
eBook Packages: Springer Book Archive